Searched for
KIRAN MAZUMDAR
Biocon chief Kiran Mazumdar-Shaw tests positive for Covid-1918 Aug, 2020, 07.50 AM IST- Kiran Mazumdar-Shaw on ET Awards for Corporate Excellence 202011 Mar, 2021, 12.21 PM IST
- Biocon posts net profit of Rs 211.59 croreET18.jpg20 Jan, 2011, 12.31 PM IST
- Agnipath scheme is a very innovative armed force reform will help young people, says Biocon chief Kiran Mazumdar Shaw20 Jun, 2022, 09.49 PM IST
- Lobbying is not bribery, says Kiran Mazumdar ShawKiran.jpg11 Dec, 2012, 05.50 PM IST
- Biocon is becoming a credible force in biosimilars: Kirankiran.jpg11 Nov, 2010, 11.05 AM IST
- Syngene is poised for strong, robust growth: Kiran Mazumdar Shaw27 Jul, 2015, 10.13 AM IST
- Kiran Mazumdar Shaw on Biocon's Q2 resultskiran.jpg22 Oct, 2010, 12.20 PM IST
- Pfizer-Biocon have amicable separation: Kiran MazumdarKiran-Mazumdar.jpg13 Mar, 2012, 09.48 PM IST
- Plan to list Syngene in August: Kiran Mazumdar Shaw24 Jun, 2015, 11.24 AM IST
- There is compelling need to focus on Biosimilar from govt, patients' point of view: Kiran Mazumdar-Shaw27 Mar, 2019, 10.56 AM IST
- "Muted earnings for Biocon this quarter", says Kiran Mazumdar-Shaw, Chairman and MD27 Oct, 2017, 12.57 PM IST
- Drug price control unilateral, rationale puzzling: Biocon16 Jul, 2014, 11.14 AM IST
- Planning to list Syngene: Biocon22 Sep, 2014, 11.58 AM IST
- Kiran Mazumdar-Shaw & Shantanu Narayen at ET CEO Roundtable12 Feb, 2021, 01.21 PM IST
- PM wants to simplify rules and regulations: Kiran Mazumdar-Shaw19 Jan, 2015, 12.22 PM IST
- Watch: Kiran Mazumdar-Shaw of Biocon Ltd talk on co's earnings27 Apr, 2018, 11.16 AM IST
- No corporate governance issue at Infosys: Kiran Mazumdar-Shaw10 Feb, 2017, 07.05 PM IST
- No corporate governance issue at Infosys: Kiran Mazumdar-Shaw10 Feb, 2017, 07.08 PM IST
- Budget should incentivise biotech sector: Kiran MazumdarKiran.jpg06 Jul, 2009, 10.08 AM IST
Load More
